Table of Contents The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis Nippon India PHARMA Fund - G
Scheme Objective
CAGR return of 22% since its launch. Ranked 35 in Sectoral category. Return for 2020 was 66.4% , 2019 was 1.7% and 2018 was 3.6% . NAV as on 24 Sep 21 ₹310.967 ↓ -4.58 (-1.45 %) Net Assets (AUM) as on 31 Aug 2021 ₹5,667 Cr. Launch Date 5 Jun 2004 Category Equity - Sectoral Rating ☆☆ Type Open Ended Fund Risk High AMC Nippon Life Asset Management Ltd. Alpha Ratio 4.33 Expense Ratio 0.96 % Sharpe Ratio 2.618 Information Ratio 1.09 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹100 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 24 Sep 21 Duration Returns 1 Month 2.1% 3 Month 4.4% 6 Month 26.4% 1 Year 42.6% 3 Year 25.1% 5 Year 16.2% 10 Year 15 Year Since launch 22% Historical Annual Returns
Year Returns 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% 2013 20.9% 2012 34.8% Growth of 10k Over Years
Date Value 31 Aug 16 ₹10,000 31 Aug 17 ₹8,562 31 Aug 18 ₹11,233 31 Aug 19 ₹9,810 31 Aug 20 ₹14,805 31 Aug 21 ₹21,906 
Asset Allocation
Asset Class Value Cash 4.77% Equity 95.23% 
Sector Allocation
Sector Value Health Care 95.23% 
Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹588 Cr 7,600,976
↑ 300,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLABDrug Manufacturers - Specialty & Generic 10% ₹540 Cr 1,100,000
↓ -50,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 500124Drug Manufacturers - Specialty & Generic 8% ₹452 Cr 960,000 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 500087Drug Manufacturers - General 8% ₹442 Cr 4,800,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMADrug Manufacturers - Specialty & Generic 8% ₹440 Cr 4,800,000
↑ 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 500257Drug Manufacturers - Specialty & Generic 7% ₹377 Cr 3,400,025 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLANDDrug Manufacturers - General 6% ₹354 Cr 900,000
↓ -150,953 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 532843Medical Care Facilities 5% ₹291 Cr 11,590,455
↓ -600,000 Thyrocare Technologies Ltd (Healthcare)
Equity, Since 31 May 16 | THYROCAREDiagnostics & Research 4% ₹246 Cr 1,883,739 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSPMedical Care Facilities 4% ₹242 Cr 600,772
↓ -91,000
Talk to our investment specialistFund Managers
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 16.35 Yr. Kinjal Desai 25 May 18 3.19 Yr. Custodians
Company Address Deutsche Bank AG Deutsche Bank AG,Kodak House, 22, D.N. Road, Registrar & Transfer Agent
KFin Technologies Private Limited Address "KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills, FAX 91-40-23311968 Email mailmanager@karvy.com Administrator Companies
Company Address Nippon India Mutual Fund 9th Floor, Crescenzo, C-38 & 39,,G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400051 Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year Nippon India Pharma Fund
Normal Dividend, Payout ₹90.2456
↓ -1.33 26.41 % 53.86 % 27.41 % 17.46 % Nippon India Pharma Fund
Normal Dividend, Reinvestment ₹90.2456
↓ -1.33 26.41 % 53.86 % 27.41 % 17.46 % Nippon India Pharma Fund
Growth ₹310.967
↓ -4.58 26.41 % 42.64 % 25.06 % 16.16 % Data as on 24 Sep 21
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2021 Shepard Technologies Private Limited. All Rights Reserved